| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |